| Literature DB >> 17570663 |
Astrid Spannhoff1, Rospita Machmur, Ralf Heinke, Patrick Trojer, Ingo Bauer, Gerald Brosch, Roland Schüle, Wolfgang Hanefeld, Wolfgang Sippl, Manfred Jung.
Abstract
Via virtual screening we identified a thioglycolic amide as an arginine methyltransferase (PRMT) inhibitor and tested it and related compounds against the fungal PRMT RmtA and human PRMT1. Compound RM65 was the most potent druglike inhibitor (IC(50)-PRMT1: 55.4 microM) and showed histone hypomethylation in HepG2 cells. Docking studies proposed binding at the substrate and SAM cofactor binding pocket. It may serve as a lead for further PRMT inhibitors useful for the treatment for hormone dependent cancers.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17570663 DOI： 10.1016/j.bmcl.2007.05.088
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN： 0960-894X Impact factor: 2.823